United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

UK Government Sets Out 2026 Branded Medicines Statutory Scheme Repayment Rate

The UK Department of Health and Social Care (DHSC) has proposed to set the repayment percentage on sales of branded "newer" prescription-only medicines to the NHS at 16.5% for 2026...

United Kingdom Healthcare

AP

Arnold & Porter

Healthcare & Life Sciences – AI Readiness & Integration Questionnaire

Artificial Intelligence (AI) is rapidly changing the way people work across the life sciences and healthcare sector.

United Kingdom Healthcare

AG

Addleshaw Goddard

UK PMCPA Releases New Guidance On Package Deals: Key Takeaways For Industry

The Prescription Medicines Code of Practice Authority (PMCPA) has published new guidance to provide clarity on the disclosure obligations and commercial governance expected from companies in relation to package deals (Guidance).

United Kingdom Healthcare

AP

Arnold & Porter

UK's Data (Use And Access) Act: What Life Sciences Companies Need To Know

The Data (Use and Access) Act 2025 ("DUAA") represents the UK's first major reform of data protection law since leaving the EU.

United Kingdom Healthcare

AP

Arnold & Porter

Is Change On The Horizon For The UK Product Liability Regime? [Updated]

United Kingdom Healthcare

AP

Arnold & Porter

European Real Estate: A Market Ready To Mobilize

European Union Real Estate

SR

McDermott Will & Schulte

Trends In Therapeutic Innovation

United Kingdom Healthcare

B

Boult Wade Tennant

UK Clinical Trials Reform: Early Growth Indicators And Key MHRA Guidance

United Kingdom Healthcare

AP

Arnold & Porter

Agritech Thymes: Unlocking The Soil Microbiome: Driving Agritech Innovation In The UK

United Kingdom IP

HL

HGF Ltd

The Antibody Series #1 Quality Characteristics (CQAs) In Antibody Claims: When The Test Method Can Remain Outside The Claim

United Kingdom IP

HL

HGF Ltd

UK Government To Issue Guidance On Industry Payment Transparency

United Kingdom Healthcare

AP

Arnold & Porter

Celltrion And Sandoz Launch Their Aflibercept Biosimilars In Europe

European Union Healthcare

GP

Goodwin Procter LLP

What Will 2026 Hold For Life Sciences And Biopharma?

United Kingdom Commercial

AO

A&O Shearman

European Commission Proposes Simplifying The Rules On EU Medical And In-Vitro Diagnostic Devices

United Kingdom Healthcare

CM

Crowell & Moring LLP

Insights From Our Future Of Data Centres Series

Worldwide Real Estate

AG

Addleshaw Goddard

Strategic Cross-border Enforcement In Asia (Video)

Worldwide International

WL

Withers LLP

What Differences Can Corporates Leverage Between US And UK Capital Markets? (Video)

United Kingdom Finance

BC

Bryan Cave Leighton Paisner

New National Minimum Wage Rates For April 2026

United Kingdom Employment

d

didlaw

Episode 23: Mergerspresso - Christmas Special (Podcast)

United Kingdom Finance

AG

Addleshaw Goddard

M&C In The News: What's Holding Back UK Life Sciences?

As the UK sets its sights on becoming the world's third-largest life sciences economy by 2035, questions around how to turn ambition into reality are growing louder.

United Kingdom IP

MC

Marks & Clerk

Precision Breeding In England: Navigating The New Regulatory Framework

On 13 November 2025, England introduced the Genetic Technology (Precision Breeding) Regulations 2025, creating a new regulatory framework for precision bred plants.

United Kingdom Healthcare

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Updates Announced To The UK-US Trade Deal See Greater Support For The Pharmaceuticals Sector

The tariffs announced earlier this year by President Donald Trump on imports from all of the United States' (US) trading partners marked a significant change in trade dynamics. Having introduced a 10% baseline tariff...

United Kingdom International

GW

Gowling WLG

SPC Waiver: No MA? UK Says Ok

The UK Patents Court has confirmed that manufacturers using the SPC manufacturing waiver can notify without overseas marketing authorisation (MA) numbers, provided updates follow when available.

United Kingdom IP

PC

Potter Clarkson

Current Life Sciences Insurance Trends And The Imperative For Specialised Coverage

United Kingdom Healthcare

BJ

Browne Jacobson

Confidentiality In Clinical Trials: Arbitration As The Preferred Route For Dispute Resolution

United Kingdom Litigation

BJ

Browne Jacobson

Climate Resilient Crops – Mitigating The Risks Of Climate Change

United Kingdom Environment

JA

J A Kemp LLP

Cross-border Collaboration In Life Sciences: How To Make It Work

Worldwide Healthcare

BJ

Browne Jacobson

Unlocking Value Creation In Healthcare: How AI Can Reverse Private Equity's Return Challenges - Part 1: HealthTech And Tech-enabled Services

United Kingdom Healthcare

A

AlixPartners

Hot Topics: Life Sciences - October 2025

United Kingdom Healthcare

AG

Addleshaw Goddard

How MHRA's International Reliance Is Shaping UK Medicine Regulation

United Kingdom Healthcare

BJ

Browne Jacobson

Technology-Enabled Care In The UK: Legal And Technical Developments To Watch

United Kingdom Healthcare

BJ

Browne Jacobson

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

United Kingdom Healthcare

AP

Arnold & Porter

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

United Kingdom Healthcare

BJ

Browne Jacobson

How MHRA's International Reliance Is Shaping UK Medicine Regulation

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is entering a new era—one defined by speed, trust, and global collaboration.

United Kingdom Healthcare

BJ

Browne Jacobson

Technology-Enabled Care In The UK: Legal And Technical Developments To Watch

Technology-enabled care ("TEC") – which includes remote monitoring, telecare, smart-home sensors and care-focused apps – has moved from niche pilot projects into mainstream health and social care across the UK

United Kingdom Healthcare

BJ

Browne Jacobson

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

Following a two year investigation, the UK's Competition and Markets Authority ("CMA") has issued its provisional findings in which it proposes to impose significant obligations on veterinary business.

United Kingdom Healthcare

AP

Arnold & Porter

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes - particularly when the underlying science defies straightforward explanation.

United Kingdom Healthcare

BJ

Browne Jacobson

The Importance Of AI In The Development Life Sciences

United Kingdom Healthcare

BJ

Browne Jacobson

AI In Medical Devices: Patent Eligibility

AI is rapidly transforming the medical device industry, enabling smarter diagnostics, personalised treatment, and real-time intelligent health monitoring.

United Kingdom IP

MC

Marks & Clerk

Article 22 Trends In Pharma M&A: Call-In Powers And Timing

Competition authorities in Europe have for years grown increasingly concerned about so-called "killer acquisitions," particularly in life sciences where targets often have high innovation potential but little or no turnover.

United Kingdom Healthcare

AP

Arnold & Porter

Interview With Citrine Informatics: AI, Data, And The Future Of Materials Science

Founded in 2013, Citrine Informatics has grown into one of the leading players in materials informatics, helping companies harness AI and data science to accelerate the design, discovery, and optimization...

United Kingdom Technology

KL

Keltie LLP

A Milestone For Precision Breeding But Will The UK-EU Reset Pause Progress?

This article provides an update to two earlier pieces I wrote in 2021 on UK and EU reforms to the regulation of gene-edited organisms: Reform of Regulation of Gene-Edited Organisms – An update...

European Union Healthcare

M

Murgitroyd

Biopharma M&A Activity – As We Enter The Latter Months Of 2025, Strategics Continue To Lead The Way

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Supporting Growth - What Does The UK's Industrial Strategy Mean For Infrastructure?

United Kingdom Energy

GW

Gowling WLG

Life After Separation: What The Future Holds For Pharma Companies And Their Divested Consumer Healthcare Divisions

United Kingdom Healthcare

AO

A&O Shearman

Immigration And The UK's Industrial Vision

United Kingdom Immigration

LS

Lewis Silkin

AI In The Healthcare Sphere: Public And Private Considerations

United Kingdom Technology

BJ

Browne Jacobson

European Biosimilar Updates – Alvotech/Advanz's MYNZEPLI Approval And Bio-Thera/STADA Tocilizumab Alliance

European Union Healthcare

GP

Goodwin Procter LLP

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

Neurotech Patents In Europe: Methods, Medical Devices, And The EPC Exclusion

United Kingdom IP

MC

Marks & Clerk

The Thursday Investment Club: The Case For Later Living

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Tackling Tech Debt, Unlocking Value In Healthcare Portfolio Companies

United Kingdom Healthcare

A

AlixPartners

Court Of Appeal Deals With Price-less Contract

United Kingdom Litigation

LS

Lewis Silkin

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

United Kingdom IP

B

Boult Wade Tennant

See more

Latest Videos

See more

Latest Trends With EMA And MHRA Inspections In The EU And UK

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Webinar: Supplementary Protection Certificates - Part Two (Video)

D

Dehns

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Deloitte Global TMT Predictions 2018 Machine Learning (Video)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More